Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies
Abstract
:1. Introduction
2. Gastroparesis in Diabetes—Pathophysiological Considerations
3. Clinical Manifestations of Gastroparesis During Ramadan
4. Diagnostic Approaches
5. Management Strategies
6. Research Prospects
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Grover, M.; Farrugia, G.; Stanghellini, V. Gastroparesis: A Turning Point in Understanding and Treatment. Gut 2019, 68, 2238–2250. [Google Scholar] [CrossRef] [PubMed]
- Young, C.F.; Moussa, M.; Shubrook, J.H. Diabetic Gastroparesis: A Review. Diabetes Spectr. 2020, 33, 290–297. [Google Scholar] [CrossRef]
- Dougherty, M.I.; Zarroli, K.; Kapur, J. Improvement in Symptomatic Gastroparesis with Increased Vagal Nerve Stimulation. Neurol. Clin. Pract. 2020, 11, e18–e19. [Google Scholar] [CrossRef]
- Caturano, A.; Cavallo, M.; Nilo, D.; Vaudo, G.; Russo, V.; Galiero, R.; Rinaldi, L.; Marfella, R.; Monda, M.; Luca, G.; et al. Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions. Gastrointest. Disord. 2024, 6, 214–229. [Google Scholar] [CrossRef]
- Horowitz, M.; O’Donovan, D.; Jones, K.L.; Feinle, C.; Rayner, C.K.; Samsom, M. Gastric Emptying in Diabetes: Clinical Significance and Treatment. Diabet. Med. 2002, 19, 177–194. [Google Scholar] [CrossRef]
- Hassanein, M.; Afandi, B.; Ahmedani, M.Y.; Alamoudi, R.M.; Alawadi, F.; Bajaj, H.S.; Basit, A.; Bennakhi, A.; Sayed, A.A.E.; Hamdy, O.; et al. Diabetes and Ramadan: Practical Guidelines 2021. Diabetes Res. Clin. Pract. 2022, 185, 109185. [Google Scholar] [CrossRef] [PubMed]
- Ibrahim, M.; Davies, M.J.; Ahmad, E.; Annabi, F.A.; Eckel, R.H.; Ba-Essa, E.M.; Sayed, N.A.E.; Fischl, A.H.; Houeiss, P.; Iraqi, H.; et al. Recommendations for Management of Diabetes during Ramadan: Update 2020, Applying the Principles of the ADA/EASD Consensus. BMJ Open Diabetes Res. Care 2020, 8, e001248. [Google Scholar] [CrossRef] [PubMed]
- Homko, C.J.; Duffy, F.; Friedenberg, F.K.; Boden, G.; Parkman, H.P. Effect of Dietary Fat and Food Consistency on Gastroparesis Symptoms in Patients with Gastroparesis. Neurogastroenterol. Motil. 2015, 27, 501–508. [Google Scholar] [CrossRef]
- Wytiaz, V.; Homko, C.; Duffy, F.; Schey, R.; Parkman, H.P. Foods Provoking and Alleviating Symptoms in Gastroparesis: Patient Experiences. Dig. Dis. Sci. 2015, 60, 1052–1058. [Google Scholar] [CrossRef]
- Ochani, R.K.; Shaikh, A.; Batra, S.; Pikale, G.; Surani, S. Diabetes among Muslims during Ramadan: A Narrative Review. World J. Clin. Cases 2023, 11, 6031–6039. [Google Scholar] [CrossRef]
- Al-Sofiani, M.E.; Alharthi, S.; Albunyan, S.; Alzaman, N.; Klonoff, D.C.; Alguwaihes, A. A Real-World Prospective Study of the Effectiveness and Safety of Automated Insulin Delivery Compared with Other Modalities of Type 1 Diabetes Treatment During Ramadan Intermittent Fasting. Diabetes Care 2024, 47, 683–691. [Google Scholar] [CrossRef]
- Choung, R.S.; Locke, R.G.; Schleck, C.D.; Zinsmeister, A.R.; Melton, J.L.; Talley, N.J. Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population. Am. J. Gastroenterol. 2012, 107, 82–88. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; Wang, L.; Long, R.; Song, L.; Yue, R. Prevalence of Gastroparesis in Diabetic Patients: A Systematic Review and Meta-Analysis. Sci. Rep. 2023, 13, 14015. [Google Scholar] [CrossRef] [PubMed]
- Camilleri, M.; Bharucha, A.E.; Farrugia, G. Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis. Clin. Gastroenterol. Hepatol. 2010, 9, 5–12. [Google Scholar] [CrossRef] [PubMed]
- Almogbel, R.A.; Alhussan, F.A.; Alnasser, S.A.; Algeffari, M.A. Prevalence and Risk Factors of Gastroparesis-Related Symptoms among Patients with Type 2 Diabetes. Int. J. Health Sci. 2016, 10, 397–404. [Google Scholar] [CrossRef]
- AlOlaiwi, L.A.; AlHarbi, T.J.; Tourkmani, A.M. Prevalence of Cardiovascular Autonomic Neuropathy and Gastroparesis Symptoms among Patients with Type 2 Diabetes Who Attend a Primary Health Care Center. PLoS ONE 2018, 13, e0209500. [Google Scholar] [CrossRef]
- Bukhari, A.A.; Alsayari, M.M. 415-P: Prevalence of Gastroparesis Symptoms in Diabetic Patients in the Western Region of Saudi Arabia, 2019. Diabetes 2021, 70, 415-P. [Google Scholar] [CrossRef]
- Sodhi, M.; Rezaeianzadeh, R.; Kezouh, A.; Etminan, M. Risk of Gastrointestinal Adverse Events Associated with Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA 2023, 330, 1795. [Google Scholar] [CrossRef]
- Parkman, H.P.; Rim, D.S.; Anolik, J.R.; Dadparvar, S.; Maurer, A.H. Glucagonlike Peptide-1 Receptor Agonists: The Good, the Bad, and the Ugly—Benefits for Glucose Control and Weight Loss with Side Effects of Delaying Gastric Emptying. J. Nucl. Med. Technol. 2024, 52, 3–7. [Google Scholar] [CrossRef]
- Farmer, A.D.; Kadirkamanathan, S.S.; Aziz, Q. Diabetic Gastroparesis: Pathophysiology, Evaluation and Management. Br. J. Hosp. Med. 2012, 73, 451–456. [Google Scholar] [CrossRef]
- Stocker, A.; Abell, T.L.; Rashed, H.; Kedar, A.; Boatright, B.; Chen, J. Autonomic Evaluation of Patients With Gastroparesis and Neurostimulation: Comparisons of Direct/Systemic and Indirect/Cardiac Measures. Gastroenterol. Res. 2016, 9, 10–16. [Google Scholar] [CrossRef]
- Travagli, R.A.; Anselmi, L. Vagal Neurocircuitry and Its Influence on Gastric Motility. Nat. Rev. Gastroenterol. Hepatol. 2016, 13, 389–401. [Google Scholar] [CrossRef] [PubMed]
- Choi, E.L.; Taheri, N.; Tan, E.; Matsumoto, K.; Hayashi, Y. The Crucial Role of the Interstitial Cells of Cajal in Neurointestinal Diseases. Biomolecules 2023, 13, 1358. [Google Scholar] [CrossRef]
- Mostafa, R.M.; Moustafa, Y.M.; Hamdy, H. Interstitial Cells of Cajal, the Maestro in Health and Disease. World J. Gastroenterol. 2010, 16, 3239. [Google Scholar] [CrossRef] [PubMed]
- Long, Q.-L.; Fang, D.-C.; Shi, H.-T.; Luo, Y.-H. Gastro-Electric Dysrhythm and Lack of Gastric Interstitial Cells of Cajal. World J. Gastroenterol. 2004, 10, 1227. [Google Scholar] [CrossRef]
- Wang, T.H.; Angeli, T.R.; Ishida, S.; Du, P.; Gharibans, A.; Paskaranandavadivel, N.; Imai, Y.; Miyagawa, T.; Abell, T.L.; Farrugia, G.; et al. The Influence of Interstitial Cells of Cajal Loss and Aging on Slow Wave Conduction Velocity in the Human Stomach. Physiol. Rep. 2020, 8, e14659. [Google Scholar] [CrossRef]
- Choi, K.M.; Kashyap, P.C.; Dutta, N.; Stoltz, G.J.; Ordog, T.; Donohue, T.S.; Bauer, A.J.; Linden, D.R.; Szurszewski, J.H.; Gibbons, S.J.; et al. CD206-Positive M2 Macrophages That Express HEME Oxygenase-1 Protect against Diabetic Gastroparesis in Mice. Gastroenterology 2010, 138, 2399–2409.e1. [Google Scholar] [CrossRef] [PubMed]
- Choi, K.M.; Gibbons, S.J.; Nguyen, T.V.; Stoltz, G.J.; Lurken, M.S.; Ordog, T.; Szurszewski, J.H.; Farrugia, G. HEME Oxygenase-1 Protects Interstitial Cells of Cajal from Oxidative Stress and Reverses Diabetic Gastroparesis. Gastroenterology 2008, 135, 2055–2064.e2. [Google Scholar] [CrossRef]
- Neshatian, L.; Gibbons, S.J.; Farrugia, G. Macrophages in Diabetic Gastroparesis—The Missing Link? Neurogastroenterol. Motil. 2014, 27, 7–18. [Google Scholar] [CrossRef]
- Camilleri, M.; Sanders, K.M. Gastroparesis. Gastroenterology 2021, 162, 68–87.e1. [Google Scholar] [CrossRef]
- Mahavadi, S.; Sriwai, W.; Manion, O.; Grider, J.R.; Murthy, K.S. Diabetes-Induced Oxidative Stress Mediates Upregulation of RhoA/Rho Kinase Pathway and Hypercontractility of Gastric Smooth Muscle. PLoS ONE 2017, 12, e0178574. [Google Scholar] [CrossRef] [PubMed]
- Giacco, F.; Brownlee, M. Oxidative Stress and Diabetic Complications. Circ. Res. 2010, 107, 1058–1070. [Google Scholar] [CrossRef] [PubMed]
- Song, B.; Zhang, G.; Bao, Y.; Zhang, M. Involvement of Oxidative Stress-AMPK-Cx43-NLRP3 Pathway in Extracellular Matrix Remodeling of Gastric Smooth Muscle Cells in Rats with Diabetic Gastroparesis. Cell Stress Chaperones 2024, 29, 440–455. [Google Scholar] [CrossRef] [PubMed]
- Stavely, R.; Ott, L.C.; Rashidi, N.; Sakkal, S.; Nurgali, K. The Oxidative Stress and Nervous Distress Connection in Gastrointestinal Disorders. Biomolecules 2023, 13, 1586. [Google Scholar] [CrossRef]
- Khoo, J.; Rayner, C.K.; Feinle-Bisset, C.; Jones, K.L.; Horowitz, M. Gastrointestinal Hormonal Dysfunction in Gastroparesis and Functional Dyspepsia. Neurogastroenterol. Motil. 2010, 22, 1270–1278. [Google Scholar] [CrossRef]
- Camilleri, M. Gastrointestinal Hormones and Regulation of Gastric Emptying. Curr. Opin. Endocrinol. Diabetes Obes. 2018, 26, 3–10. [Google Scholar] [CrossRef]
- Murray, C.D.R. Ghrelin Enhances Gastric Emptying in Diabetic Gastroparesis: A Double Blind, Placebo Controlled, Crossover Study. Gut 2005, 54, 1693–1698. [Google Scholar] [CrossRef]
- Mani, B.K.; Shankar, K.; Zigman, J.M. Ghrelin’s Relationship to Blood Glucose. Endocrinology 2019, 160, 1247–1261. [Google Scholar] [CrossRef]
- Plummer, M.P.; Jones, K.L.; Cousins, C.E.; Trahair, L.G.; Meier, J.J.; Chapman, M.J.; Horowitz, M.; Deane, A.M. Hyperglycemia Potentiates the Slowing of Gastric Emptying Induced by Exogenous GLP-1. Diabetes Care 2015, 38, 1123–1129. [Google Scholar] [CrossRef]
- Goyal, R.K. Gastric Emptying Abnormalities in Diabetes Mellitus. N. Engl. J. Med. 2021, 384, 1742–1751. [Google Scholar] [CrossRef]
- Pasricha, P.J.; Pehlivanov, N.D.; Gomez, G.; Vittal, H.; Lurken, M.S.; Farrugia, G. Changes in the Gastric Enteric Nervous System and Muscle: A Case Report on Two Patients with Diabetic Gastroparesis. BMC Gastroenterol. 2008, 8, 21. [Google Scholar] [CrossRef] [PubMed]
- Faussone-Pellegrini, M.S.; Grover, M.; Pasricha, P.J.; Bernard, C.E.; Lurken, M.S.; Smyrk, T.C.; Parkman, H.P.; Abell, T.L.; Snape, W.J.; Hasler, W.L.; et al. Ultrastructural Differences between Diabetic and Idiopathic Gastroparesis. J. Cell. Mol. Med. 2011, 16, 1573–1581. [Google Scholar] [CrossRef] [PubMed]
- Selim, M.M.; Wendelschafer-Crabb, G.; Redmon, J.B.; Khoruts, A.; Hodges, J.S.; Koch, K.; Walk, D.; Kennedy, W.R. Gastric Mucosal Nerve Density. Neurology 2010, 75, 973–981. [Google Scholar] [CrossRef]
- Padma, V.; Gurukul, S.M.K.; Vignesh; Javid, S.M. Gastric Mucosal Changes in Type 2 Diabetic Patients. World J. Med. Sci. 2014, 10, 129–134. [Google Scholar]
- Shankar, A.; Sharma, A.; Vinas, A.; Chilton, R.J. GLP-1 Receptor Agonists and Delayed Gastric Emptying: Implications for Invasive Cardiac Interventions and Surgery. Cardiovasc. Endocrinol. Metab. 2024, 14, e00321. [Google Scholar] [CrossRef]
- Odukanmi, O.A.; Anyagwa, O.E.; Adewunmi, O.S.; Okechukwu, K.I.; Olaleye, S.B. Extended Fasting Durations Delayed Gastric Emptying and Colonic Motility in Normal Male Rats. J. Biosci. Med. 2022, 10, 146–154. [Google Scholar] [CrossRef]
- Jones, R.B.; Dockray, G.J.; Thompson, D.G. The Effects of Fasting Duration on Gastric Emptying in Man, an Exploration of the Role of the Endocannabinoid System and Inter-individual Responsiveness. Neurogastroenterol. Motil. 2012, 24, 928. [Google Scholar] [CrossRef]
- Ohno, T.; Mochiki, E.; Kuwano, H. The Roles of Motilin and Ghrelin in Gastrointestinal Motility. Int. J. Pept. 2010, 2010, 820794. [Google Scholar] [CrossRef]
- Liddle, R.A.; Morita, E.T.; Conrad, C.K.; Williams, J.A. Regulation of Gastric Emptying in Humans by Cholecystokinin. J. Clin. Investig. 1986, 77, 992–996. [Google Scholar] [CrossRef]
- Murray, H.B.; Becker, K.R.; Harshman, S.; Breithaupt, L.; Kuhnle, M.; Dreier, M.J.; Hauser, K.; Freizinger, M.; Eddy, K.T.; Misra, M.; et al. Elevated Fasting Satiety-Promoting Cholecystokinin (CCK) in Avoidant/Restrictive Food Intake Disorder Compared to Healthy Controls. J. Clin. Psychiatry 2022, 83, 21m14111. [Google Scholar] [CrossRef]
- Dressman, J.B.; Berardi, R.R.; Dermentzoglou, L.C.; Russell, T.L.; Schmaltz, S.P.; Barnett, J.L.; Jarvenpaa, K.M. Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women. Pharm. Res. 1990, 07, 756–761. [Google Scholar] [CrossRef] [PubMed]
- Litou, C.; Vertzoni, M.; Goumas, C.; Vasdekis, V.; Xu, W.; Kesisoglou, F.; Reppas, C. Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State under Hypo- and a-Chlorhydric Gastric Conditions under Conditions of Typical Drug—Drug Interaction Studies. Pharm. Res. 2016, 33, 1399–1412. [Google Scholar] [CrossRef]
- Olausson, E.A.; Alpsten, M.; Larsson, A.; Mattsson, H.; Andersson, H.; Attvall, S. Small Particle Size of a Solid Meal Increases Gastric Emptying and Late Postprandial Glycaemic Response in Diabetic Subjects with Gastroparesis. Diabetes Res. Clin. Pract. 2008, 80, 231–237. [Google Scholar] [CrossRef]
- Jehangir, A.; Parkman, H.P. Reflux Symptoms in Gastroparesis. J. Clin. Gastroenterol. 2019, 54, 428–438. [Google Scholar] [CrossRef] [PubMed]
- Parkman, H.P.; Van Natta, M.; Yamada, G.; Grover, M.; McCallum, R.W.; Sarosiek, I.; Farrugia, G.; Koch, K.L.; Abell, T.L.; Kuo, B.; et al. Body Weight in Patients with Idiopathic Gastroparesis. Neurogastroenterol. Motil. 2020, 33, e13974. [Google Scholar] [CrossRef]
- De Fano, M.; Porcellati, F.; Fanelli, C.G.; Corio, S.; Mazzieri, A.; Lucidi, P.; Bolli, G.B.; Bassotti, G. The Role of Gastric Emptying in Glucose Homeostasis and Defense against Hypoglycemia: Innocent Bystander or Partner in Crime? Diabetes Res. Clin. Pract. 2023, 203, 110828. [Google Scholar] [CrossRef]
- Goyal, R.K.; Cristofaro, V.; Sullivan, M.P. Rapid Gastric Emptying in Diabetes Mellitus: Pathophysiology and Clinical Importance. J. Diabetes Its Complicat. 2019, 33, 107414. [Google Scholar] [CrossRef] [PubMed]
- Mihai, B.M.; Mihai, C.; Cijevschi-Prelipcean, C.; Grigorescu, E.-D.; Dranga, M.; Drug, V.; Sporea, I.; Lăcătușu, C.M. Bidirectional Relationship between Gastric Emptying and Plasma Glucose Control in Normoglycemic Individuals and Diabetic Patients. J. Diabetes Res. 2018, 2018, 1736959. [Google Scholar] [CrossRef]
- Nationella Diabetesregistret (NDR). Årsrapport Nationella Diabetesregistret 2023; Nationella Diabetesregistret: Gothenburg, Sweden, 2023; p. 72. Available online: https://registercentrum.blob.core.windows.net/ndr/r/-rsrapport-Nationella-Diabetesregistret-2023-gCM79vAxQ.pdf (accessed on 6 February 2025).
- Maselli, D.B.; Camilleri, M. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity. Adv. Exp. Med. Biol. 2020, 1307, 171–192. [Google Scholar] [CrossRef]
- Kalas, M.A.; Dang, Q.; Galura, G.; Alvarado, L.; Dwivedi, A.K.; Deoker, A.; McCallum, R. Frequency of GLP-1 Receptor Agonists Use in Diabetic Patients Diagnosed with Delayed Gastric Emptying and Their Demographic Profile. J. Investig. Med. 2022, 71, 11–16. [Google Scholar] [CrossRef]
- Jalleh, R.J.; Plummer, M.P.; Marathe, C.S.; Umapathysivam, M.M.; Quast, D.R.; Rayner, C.K.; Jones, K.L.; Wu, T.; Horowitz, M.; Nauck, M.A. Clinical Consequences of Delayed Gastric Emptying with GLP-1 Receptor Agonists and Tirzepatide. J. Clin. Endocrinol. Metab. 2024, 110, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Mason, I.C.; Qian, J.; Adler, G.K.; Scheer, F.A.J.L. Impact of Circadian Disruption on Glucose Metabolism: Implications for Type 2 Diabetes. Diabetologia 2020, 63, 462–472. [Google Scholar] [CrossRef] [PubMed]
- Goo, R.H.; Moore, J.G.; Greenberg, E.; Alazraki, N.P. Circadian Variation in Gastric Emptying of Meals in Humans. Gastroenterology 1987, 93, 515–518. [Google Scholar] [CrossRef]
- Voigt, R.M.; Forsyth, C.B.; Keshavarzian, A. Circadian Rhythms: A Regulator of Gastrointestinal Health and Dysfunction. Expert Rev. Gastroenterol. Hepatol. 2019, 13, 411–424. [Google Scholar] [CrossRef]
- Nguyen, L.; Wilson, L.A.; Miriel, L.; Pasricha, P.J.; Kuo, B.; Hasler, W.L.; McCallum, R.W.; Sarosiek, I.; Koch, K.L.; Snape, W.J.; et al. Autonomic Function in Gastroparesis and Chronic Unexplained Nausea and Vomiting: Relationship with Etiology, Gastric Emptying, and Symptom Severity. Neurogastroenterol. Motil. 2020, 32, e13810. [Google Scholar] [CrossRef] [PubMed]
- Mohammad, M.K.; Pepper, D.J.; Kedar, A.; Bhaijee, F.; Familoni, B.; Rashed, H.; Cutts, T.; Abell, T.L. Measures of Autonomic Dysfunction in Diabetic and Idiopathic Gastroparesis. Gastroenterol. Res. 2016, 9, 65–69. [Google Scholar] [CrossRef]
- Tang, D.M.; Friedenberg, F.K. Gastroparesis: Approach, Diagnostic Evaluation, and Management. Disease-a-Month 2011, 57, 74–101. [Google Scholar] [CrossRef]
- Ghazanfar, H.; Allena, N.; Javed, N.; Ponnachan, D.; Narasimhadevara, S.; Komadur, T.; Ghazanfar, A.; Acherjee, T.; Patel, H. Diagnostic Modalities Used in Diagnosing Gastroparesis: A Clinical Review. Cureus 2022, 14, e30540. [Google Scholar] [CrossRef]
- Revicki, D.A.; Rentz, A.M.; Dubois, D.; Kahrilas, P.; Stanghellini, V.; Talley, N.J.; Tack, J. Gastroparesis Cardinal Symptom Index (GCSI): Development and Validation of a Patient Reported Assessment of Severity of Gastroparesis Symptoms. Qual. Life Res. 2004, 13, 833–844. [Google Scholar] [CrossRef]
- Khayyam, U.; Sachdeva, P.; Gomez, J.; Ramzan, Z.; Smith, M.S.; Maurer, A.H.; Fisher, R.S.; Parkman, H.P. Assessment of Symptoms during Gastric Emptying Scintigraphy to Correlate Symptoms to Delayed Gastric Emptying. Neurogastroenterol. Motil. 2010, 22, 539–545. [Google Scholar] [CrossRef]
- Grad, S.; Poanta, L.; Dumitrascu, D.; Dragoteanu, M.; Porojan, M. Correlation between Symptoms of Diabetic Gastroparesis and Results of Gastric Scintigraphy. Open Med. 2011, 7, 20–24. [Google Scholar] [CrossRef]
- Cassilly, D.W.; Wang, Y.R.; Friedenberg, F.K.; Nelson, D.B.; Maurer, A.H.; Parkman, H.P. Symptoms of Gastroparesis: Use of the Gastroparesis Cardinal Symptom Index in Symptomatic Patients Referred for Gastric Emptying Scintigraphy. Digestion 2008, 78, 144–151. [Google Scholar] [CrossRef]
- Sato, H.; Grover, M. Gastroparesis and Functional Dyspepsia: Spectrum of Gastroduodenal Neuromuscular Disorders or Unique Entities? Gastro Hep Adv. 2022, 2, 438–448. [Google Scholar] [CrossRef] [PubMed]
- Mandarino, F.V.; Testoni, S.G.G.; Barchi, A.; Azzolini, F.; Sinagra, E.; Pepe, G.; Chiti, A.; Danese, S. Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment. Life 2023, 13, 1743. [Google Scholar] [CrossRef]
- Farrell, M.B. Gastric Emptying Scintigraphy. J. Nucl. Med. Technol. 2019, 47, 111–119. [Google Scholar] [CrossRef]
- Sangnes, D.A.; Søfteland, E.; Bekkelund, M.; Frey, J.; Biermann, M.; Gilja, O.H.; Dimcevski, G. Wireless Motility Capsule Compared with Scintigraphy in the Assessment of Diabetic Gastroparesis. Neurogastroenterol. Motil. 2019, 32, e13771. [Google Scholar] [CrossRef]
- Darwiche, G.; Björgell, O.; Thorsson, O.; Almér, L.-O. Correlation between Simultaneous Scintigraphic and Ultrasonographic Measurement of Gastric Emptying in Patients with Type 1 Diabetes Mellitus. J. Ultrasound Med. 2003, 22, 459–466. [Google Scholar] [CrossRef] [PubMed]
- Ramzan, Z.; Duffy, F.; Gomez, J.; Fisher, R.S.; Parkman, H.P. Continuous Glucose Monitoring in Gastroparesis. Dig. Dis. Sci. 2011, 56, 2646–2655. [Google Scholar] [CrossRef]
- Cichosz, S.L.; Hejlesen, O. Classification of Gastroparesis from Glycemic Variability in Type 1 Diabetes: A Proof-of-Concept Study. J. Diabetes Sci. Technol. 2021, 16, 1190–1195. [Google Scholar] [CrossRef]
- Krishnasamy, S.; Abell, T.L. Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes Ther. 2018, 9, 1–42. [Google Scholar] [CrossRef]
- Egboh, S.-M.C.; Abere, S. Gastroparesis: A Multidisciplinary Approach to Management. Cureus 2022, 14, e21295. [Google Scholar] [CrossRef] [PubMed]
- Eseonu, D.; Su, T.; Lee, K.; Chumpitazi, B.P.; Shulman, R.J.; Hernaez, R. Dietary Interventions for Gastroparesis: A Systematic Review. Adv. Nutr. 2022, 13, 1715–1724. [Google Scholar] [CrossRef]
- Waseem, S.; Moshiree, B.; Draganov, P.V. Gastroparesis: Current Diagnostic Challenges and Management Considerations. World J. Gastroenterol. 2008, 15, 25. [Google Scholar] [CrossRef]
- Pouderoux, P.; Friedman, N.; Shirazi, P.; Ringelstein, J.G.; Keshavarzian, A. Effect of Carbonated Water on Gastric Emptying and Intragastric Meal Distribution. Dig. Dis. Sci. 1997, 42, 34–39. [Google Scholar] [CrossRef] [PubMed]
- Boekema, P.J.; Samsom, M.; van Berge Henegouwen, G.P.; Smout, A.J. Coffee and Gastrointestinal Function: Facts and Fiction: A Review. Scand. J. Gastroenterol. 1999, 34, 35–39. [Google Scholar] [CrossRef]
- Aldawi, N.; Darwiche, G.; Abusnana, S.; Elbagir, M.; Elgzyri, T. Initial Increase in Glucose Variability during Ramadan Fasting in Non-Insulin-Treated Patients with Diabetes Type 2 Using Continuous Glucose Monitoring. Libyan J. Med. 2018, 14, 1535747. [Google Scholar] [CrossRef]
- Alayed, K.M. Glucagon-Like Peptide-1 (GLP-1) during Ramadan: Narrative Review of the Published Literature. J. Obes. 2023, 2023, 8626081. [Google Scholar] [CrossRef]
- Gorgojo-Martínez, J.J.; Mezquita-Raya, P.; Carretero-Gómez, J.; Castro, A.; Cebrián-Cuenca, A.; De Torres-Sánchez, A.; García-De-Lucas, M.D.; Núñez, J.; Obaya, J.C.; Soler, M.J.; et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J. Clin. Med. 2022, 12, 145. [Google Scholar] [CrossRef]
- Reddymasu, S.C.; Soykan, I.; McCallum, R.W. Domperidone: Review of Pharmacology and Clinical Applications in Gastroenterology. Am. J. Gastroenterol. 2007, 102, 2036–2045. [Google Scholar] [CrossRef]
- Isola, S.; Hussain, A.; Dua, A.; Singh, K.; Adams, N. Metoclopramide. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2025. Available online: https://www.ncbi.nlm.nih.gov/books/NBK519517/ (accessed on 6 February 2025).
- Junqueira, D.R.; Bennett, D.; Huh, S.Y.; Fahrbach, K.; Neupane, B.; Betts, M. Risk of Adverse Events Associated with Domperidone and Metoclopramide in Gastroparesis: Systematic Review and Meta-Analysis. Drugs R&D 2023, 23, 1–20. [Google Scholar] [CrossRef]
- European Medicines Agency (EMA). Restrictions on the Use of Domperidone-Containing Medicines. EMA/356898/2014; 2014. Available online: https://www.ema.europa.eu/en/documents/referral/domperidone-article-31-referral-restrictions-use-domperidone-containing-medicines_en.pdf (accessed on 27 February 2025).
- European Medicines Agency (EMA). European Medicines Agency Recommends Changes to the Use of Metoclopramide. EMA/512788/2013; 2013. Available online: https://www.ema.europa.eu/en/documents/press-release/european-medicines-agency-recommends-changes-use-metoclopramide_en.pdf (accessed on 27 February 2025).
- U.S. Food and Drug Administration (FDA). Information About Domperidone. In FDA Drug Safety Information; FDA: Silver Spring, MD, USA, 2022. Available online: https://www.fda.gov/drugs/information-drug-class/information-about-domperidone (accessed on 27 February 2025).
- Camilleri, M.; Chedid, V.; Ford, A.C.; Haruma, K.; Horowitz, M.; Jones, K.L.; Low, P.A.; Park, S.-Y.; Parkman, H.P.; Stanghellini, V. Gastroparesis. Nat. Rev. Dis. Primers 2018, 4, 41. [Google Scholar] [CrossRef] [PubMed]
- Abolaban, H.; Moujahed, A.A. Muslim Patients in Ramadan: A Review for Primary Care Physicians. Avicenna J. Med. 2017, 7, 81–87. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Abdulrasak, M.; Shaat, N.; Someili, A.M.; Mohrag, M. Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies. J. Clin. Med. 2025, 14, 1997. https://doi.org/10.3390/jcm14061997
Abdulrasak M, Shaat N, Someili AM, Mohrag M. Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies. Journal of Clinical Medicine. 2025; 14(6):1997. https://doi.org/10.3390/jcm14061997
Chicago/Turabian StyleAbdulrasak, Mohammed, Nael Shaat, Ali M. Someili, and Mostafa Mohrag. 2025. "Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies" Journal of Clinical Medicine 14, no. 6: 1997. https://doi.org/10.3390/jcm14061997
APA StyleAbdulrasak, M., Shaat, N., Someili, A. M., & Mohrag, M. (2025). Unmasking Gastroparesis in Diabetes During Ramadan: Challenges and Management Strategies. Journal of Clinical Medicine, 14(6), 1997. https://doi.org/10.3390/jcm14061997